1.Tincani A, Andreoli L, Cavazzana I, et al. Novel aspects of Sjogren’s syndrome in 2012. BMC medicine 2013; 11: 93. 2013/04/06. DOI: 10.1186/1741–7015–11–93.
2.Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, et al. Primary Sjogren syndrome. BMJ (Clinical research ed) 2012; 344: e3821. 2012/06/16. DOI: 10.1136/bmj.e3821.
3.Mavragani CP and Moutsopoulos HM. The geoepidemiology of Sjogren’s syndrome. Autoimmunity reviews 2010; 9: A305–310. 2009/11/12. DOI: 10.1016/j.autrev.2009.11.004.
4.Siamopoulou-Mavridou A, Manoussakis MN, Mavridis AK, et al. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Annals of the rheumatic diseases 1988; 47: 982–987. 1988/12/01. DOI: 10.1136/ard.47.12.982.
5.Skopouli FN, Papanikolaou S, Malamou-Mitsi V, et al. Obstetric and gynaecological profile in patients with primary Sjogren’s syndrome. Annals of the rheumatic diseases 1994; 53: 569–573. 1994/09/01. DOI: 10.1136/ard.53.9.569.
6.Gupta S and Gupta N. Sjogren Syndrome and Pregnancy: A Literature Review. The Permanente journal 2017; 21 2017/01/13. DOI: 10.7812/tpp/16–047.
7.Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the rheumatic diseases 2002; 61: 554–558. 2002/05/15. DOI: 10.1136/ard.61.6.554.
8.Brucato A, Jonzon A, Friedman D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus 2003; 12: 427–435. 2003/07/23. DOI: 10.1191/0961203303lu408oa.
9.Stone S, Pijnenborg R, Vercruysse L, et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006; 27: 457–467. 2005/07/12. DOI: 10.1016/j.placenta.2005.04.006.
10.De Carolis S, Salvi S, Botta A, et al. The impact of primary Sjogren’s syndrome on pregnancy outcome: our series and review of the literature. Autoimmunity reviews 2014; 13: 103–107. 2013/09/21. DOI: 10.1016/j.autrev.2013.09.003.
11.Luo Y, Zhang L, Fei Y, et al. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years—a retrospective cohort study. Clinical rheumatology 2015; 34: 1721–1728. 2015/09/20. DOI: 10.1007/s10067–015–3050–7.
12.Julkunen H, Kaaja R, Kurki P, et al. Fetal outcome in women with primary Sjogren’s syndrome. A retrospective case-control study. Clinical and experimental rheumatology 1995; 13: 65–71. 1995/01/01.
13.Upala S, Yong WC and Sanguankeo A. Association between primary Sjogren’s syndrome and pregnancy complications: a systematic review and meta-analysis. Clinical rheumatology 2016; 35: 1949–1955. 2016/06/09. DOI: 10.1007/s10067–016–3323–9.
14.Corrections. The Lancet Infectious diseases 2015; 15: 505. 2015/05/02. DOI: 10.1016/s1473–3099(14)71016–3.
15.Brucato A, Franceschini F, Gasparini M, et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. The Journal of rheumatology 1995; 22: 533–540. 1995/03/01.
16.Julkunen H, Kurki P, Kaaja R, et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis and rheumatism 1993; 36: 1588–1598. 1993/11/01.
17.Kovats S. Climate change, crop yields, and undernutrition, with Sari Kovats by Ashley Ahearn. Environmental health perspectives 2011; 119: http://dx.doi.org/10.1289/ehp.trp120111. 2012/01/13.
18.Hussein SZ, Jacobsson LT, Lindquist PG, et al. Pregnancy and fetal outcome in women with primary Sjogren’s syndrome compared with women in the general population: a nested case-control study. Rheumatology 2011; 50: 1612–1617. 2011/05/03. DOI: 10.1093/rheumatology/ker077.
19.Ballester C, Grobost V, Roblot P, et al. Pregnancy and primary Sjogren’s syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies. Scandinavian journal of rheumatology 2017; 46: 56–63. 2016/05/19. DOI: 10.3109/03009742.2016.1158312.
20.Haga HJ, Gjesdal CG, Koksvik HS, et al. Pregnancy outcome in patients with primary Sjogren’s syndrome. a case-control study. The Journal of rheumatology 2005; 32: 1734–1736. 2005/09/06.
21.Carvalheiras G, Faria R, Braga J, et al. Fetal outcome in autoimmune diseases. Autoimmunity reviews 2012; 11: A520–530. 2011/12/27. DOI: 10.1016/j.autrev.2011.12.002.
22.Priori R, Gattamelata A, Modesti M, et al. Outcome of pregnancy in Italian patients with primary Sjogren syndrome. The Journal of rheumatology 2013; 40: 1143–1147. 2013/06/05. DOI: 10.3899/jrheum.121518.
23.Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012; 126: 76–82. 2012/05/26. DOI: 10.1161/circulationaha.111.089268.
24.ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstetrics and gynecology 2018; 132: e44-e52. 2018/06/26. DOI: 10.1097/aog.0000000000002708.